[THE INVESTOR] On Sept. 30, Peptron (087010) declined 4.24% to 47,400 won (US$43.04). It had increased 9.97% through the past month. Standard deviation, which indicates risk, records 2.2% over the same period over one month.

- Among its peer group, it has low Volatility, high Earning Rate - All related stocks also decline. Pharmacy industry -1.47% - Individuals and Foreigners sell, Institutions buy - Turnover Rate and Price Range both proper - The main shareholding group is Individuals

Compared with its close competitors within the same industry, KOSDAQ, the monthly earnings rate of Peptron was the highest, while its volatility within one month was at a proper rate. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 4.5. Even though the volatility was not so low, the high return lead the return-on-risk to a high level. Moreover, compared with the KOSDAQ industry, the return-on-risk is much better than the industrial mean, 3.6, and thus the industrial comparison performance was good.

While institutions have been buying Peptron during the past six trading days, foreigners have been selling during the past three trading days. As a shareholding sum by investor group for the past four weeks, institutions have bought 59,151 shares with trending trade. However, during the same period, foreigners have sold 39,958 shares with maintenance of a selling position and individuals have sold 19,193 shares as they turn toward a selling stance.

Cumulated shareholdings per investor group (1Mo)		Total shareholdings per investor group

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.